Independent prognostic factors in patients with liver cirrhosis

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 1034-1040

  Piekarska, Anna ^a,b   Zboinska, Joanna ^a   Szymczak, Wieslaw ^a   Kuydowicz, Jan ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b Department of Infectious Diseases and Hepatology ^*  (Poland)

Author keywords

Ascites; Bleeding; CTP score; Hepato renal syndrome; Independent prognostic factors; Liver cirrhosis; MELD score; Peripheral edema; Prognosis

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 47149107485     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Habib S, Berk B, Chang CC, et al: MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12:440-447.
2. Pugh RNH: Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60:646.
3. Malinchoc M, Kamath PS, Gordon FD, et al: A model to predict poor survival in patients underdoing transjugular intrahepatic shunts. Hepatology 2000; 31:864-871.
4. Said A, Williams J, Holden J, et al: Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40:897-903.
5. Ruf AE, Kremers WK, Chavez LL, et al: Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11:336-343.
6. Wiesner RH: Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 2005; 11:261-263.
7. Huo TI, Lin HC, Lee FY, et al: Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int 2006; 26:55-61.
8. Sumskiene J, Kupcinskas L, Pundzius J, Sumskas L: Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas) 2005; 41:39-46.
9. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, et al: A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34:46-52.
10. Planas R, Balleste B, Alvarez MA, et al: Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004; 40:823-830.
11. Pessione F, Ramond MJ, Peters L, et al: Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23:45-53.
12. Yoneyama K, Taniguchi H, Kiuchi Y, et al: Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma. Scand J Gastroenterol 2004; 39:1272-1279.
13. Wang JY, Liu HY, Zhu WN, et al: An analysis of prognostic factors in cirrhosis. Chin Med J 1989; 102:266-272.
14. Gentilini P, Laffi G, La Villa G, et al: Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997; 92:66-72.
15. Ribeiro LC, Saragoca A, De Moura MC: Prognostic factors and survival model for decompensated hepatic cirrhosis. Acta Med Port 1999; 4:199-204.
16. Biggins SW, Rodriguez HJ, Bacchetti P, et al: Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-39.
17. Heuman DM, Abou-Assi SG, Habib A, et al: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810.
18. Zoli M, Cordiani MR, Marchesini G, et al: Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991; 86:1508-1513.
19. Pignon JP, Poynard T, Naveau S, et al: Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis. Gastroenterol Clin Biol 1986; 10:461-467.
20. Merkel C, Bolognesi M, Angeli P, et al: Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 1989; 84:717-722.
21. Chan CW, Carpenter JR, Rigamonti C, et al: Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model. Scand J Gastroenterol 2005; 40:1081-1089.
22. Moreau R, Delegue P, Pessione F, et al: Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int 2004; 24:457-464.
23. Pessione F, Ramond MJ, Peters L, et al: Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23:45-53.
24. Kobayashi M, Ikeda K, Hosaka T, et al: Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections. J Med Virol 2006; 78:459-465.
25. Sola R, Alvarez MA, Balleste B, et al: Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Liver Int 2006; 26:62-72.
26. Chernev K, Isa S, Bakalov V, Aleksiev CH: The evolution and prognosis of liver cirrhosis patients. III. An evaluation of the survival rate and mortality using graphic mathematical models. Vutr Boles 1990; 29:67-71.